Growth Metrics

TransMedics (TMDX) Net Cash Flow (2018 - 2026)

TransMedics has reported Net Cash Flow over the past 8 years, most recently at $22.1 million for Q4 2025.

  • For Q4 2025, Net Cash Flow rose 205.09% year-over-year to $22.1 million; the TTM value through Dec 2025 reached $150.4 million, up 361.07%, while the annual FY2025 figure was $150.4 million, 361.07% up from the prior year.
  • Net Cash Flow for Q4 2025 was $22.1 million at TransMedics, down from $65.6 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $386.8 million in Q2 2023 and troughed at -$155.2 million in Q3 2023.
  • A 5-year average of $23.2 million and a median of $503000.0 in 2021 define the central range for Net Cash Flow.
  • Biggest five-year swings in Net Cash Flow: surged 6821.28% in 2022 and later crashed 772.79% in 2023.
  • Year by year, Net Cash Flow stood at $3.4 million in 2021, then plummeted by 210.18% to -$3.7 million in 2022, then crashed by 772.79% to -$32.6 million in 2023, then soared by 122.22% to $7.2 million in 2024, then soared by 205.09% to $22.1 million in 2025.
  • Business Quant data shows Net Cash Flow for TMDX at $22.1 million in Q4 2025, $65.6 million in Q3 2025, and $89.6 million in Q2 2025.